KIMOU ENVIRON (06805) repurchased 408,000 shares for approximately HK$1.2136 million on September 25.
KIMOU ENVIRON (06805) announced that on September 25, 2026, it repurchased 408,000 shares for approximately HK$1.2136 million.
KIMOU ENVIRON (06805) announced that on September 25, 2026, it repurchased 408,000 shares for approximately HK$1.2136 million.
Related Articles
Sichuan Biokin Pharmaceutical (688506.SH): T-Bren included in the breakthrough therapy designation list
Sichuan Biokin Pharmaceutical (688506.SH): BL-M05D1 for Injection Included in the Breakthrough Therapy Designation List
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): T-Bren included in the breakthrough therapy designation list
Sichuan Biokin Pharmaceutical (688506.SH): BL-M05D1 for Injection Included in the Breakthrough Therapy Designation List
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
